中国民族民间医药
中國民族民間醫藥
중국민족민간의약
CHINESE JOURNAL OF ETHNOMEDICINE AND ETHNOPHARMACY
2015年
15期
97-98,100
,共3页
陈润强%陈彩蓉%颜秋霞%冼英杰
陳潤彊%陳綵蓉%顏鞦霞%冼英傑
진윤강%진채용%안추하%승영걸
复方玄驹胶囊%Ⅲ型前列腺炎%性功能障碍%焦虑
複方玄駒膠囊%Ⅲ型前列腺炎%性功能障礙%焦慮
복방현구효낭%Ⅲ형전렬선염%성공능장애%초필
Compound Xuanju capsule%Ⅲ prostatitis%sexual dysfunction%anxiety
目的:观察复方玄驹胶囊治疗60例前列腺炎并性功能障碍患者的疗效,并探究其临床适用性。方法:选择120例Ⅲ型前列腺炎并性功能障碍患者作为研究对象,分为研究组和对照组各60例。对照组患者采用口服左氧氟沙星胶囊进行治疗,研究组患者在对照组的基础上给予复方玄驹胶囊进行治疗。观察治疗前后两组患者 NIH -CPSI、ⅡEF -5、SAS 评分;并比较两组患者治疗后勃起功能、不良反应及临床疗效。结果:治疗前,两组患者的 NIH -CPSI、ⅡEF -5、SAS 指标基本相符,差异均无统计学意义(P >0.05);治疗后,研究组患者的 NIH -CPSI、ⅡEF -5、SAS 指标均优于对照组,两组比较,差异均具有统计学意义(P <0.05);研究组患者治疗后的勃起功能以及总有效率均显著优于对照组,两组比较,差异具有统计学意义(P <0.05)。结论:复方玄驹胶囊在治疗Ⅲ型前列腺炎并性功能障碍患者的效果显著,可以明显改善患者的勃起功能,减少患者的焦虑感,安全可靠,值得临床推广应用。
目的:觀察複方玄駒膠囊治療60例前列腺炎併性功能障礙患者的療效,併探究其臨床適用性。方法:選擇120例Ⅲ型前列腺炎併性功能障礙患者作為研究對象,分為研究組和對照組各60例。對照組患者採用口服左氧氟沙星膠囊進行治療,研究組患者在對照組的基礎上給予複方玄駒膠囊進行治療。觀察治療前後兩組患者 NIH -CPSI、ⅡEF -5、SAS 評分;併比較兩組患者治療後勃起功能、不良反應及臨床療效。結果:治療前,兩組患者的 NIH -CPSI、ⅡEF -5、SAS 指標基本相符,差異均無統計學意義(P >0.05);治療後,研究組患者的 NIH -CPSI、ⅡEF -5、SAS 指標均優于對照組,兩組比較,差異均具有統計學意義(P <0.05);研究組患者治療後的勃起功能以及總有效率均顯著優于對照組,兩組比較,差異具有統計學意義(P <0.05)。結論:複方玄駒膠囊在治療Ⅲ型前列腺炎併性功能障礙患者的效果顯著,可以明顯改善患者的勃起功能,減少患者的焦慮感,安全可靠,值得臨床推廣應用。
목적:관찰복방현구효낭치료60례전렬선염병성공능장애환자적료효,병탐구기림상괄용성。방법:선택120례Ⅲ형전렬선염병성공능장애환자작위연구대상,분위연구조화대조조각60례。대조조환자채용구복좌양불사성효낭진행치료,연구조환자재대조조적기출상급여복방현구효낭진행치료。관찰치료전후량조환자 NIH -CPSI、ⅡEF -5、SAS 평분;병비교량조환자치료후발기공능、불량반응급림상료효。결과:치료전,량조환자적 NIH -CPSI、ⅡEF -5、SAS 지표기본상부,차이균무통계학의의(P >0.05);치료후,연구조환자적 NIH -CPSI、ⅡEF -5、SAS 지표균우우대조조,량조비교,차이균구유통계학의의(P <0.05);연구조환자치료후적발기공능이급총유효솔균현저우우대조조,량조비교,차이구유통계학의의(P <0.05)。결론:복방현구효낭재치료Ⅲ형전렬선염병성공능장애환자적효과현저,가이명현개선환자적발기공능,감소환자적초필감,안전가고,치득림상추엄응용。
Objective To investigate the efficacy of 60 cases patients of prostatitis and sexual dysfunction with compound Xuanju capsules,and to explore its clinical applicability.Methods Select 120 cases of type Ⅲ prostatitis and sexual dysfunction patients, they were divided into the study group and control group,the control group were treated with oral Levofloxacin capsule treatment,the study group were given compound Xuanju capsules for treatment.Compared and observed before and after treatment NIH -CPSI,ⅡEF -5,SAS score;erectile function,adverse reactions and clinical efficacy of the two groups.Results After treatment,the two groups of patients with NIH -CPSI,ⅡEF -5,SAS were improved compared with before treatment;the NIH -CPSI,ⅡEF -5, SAS index of the study group were better than the control group,the difference were statistically significant (P <0.05);Erectile function and the total effective rate of the study group were significantly better than the control group,the difference were statistically significant (P <0.05).Conclusion Compound XuanJu capsule in the treatment of type Ⅲ prostatitis and sexual dysfunction in pa-tients has obvious effect,it can better improve erectile function,and it is suitable for clinical application for a long time.